Stay updated on INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.

Latest updates to the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page
- Check13 days agoChange DetectedAdded two keywords/MeSH terms: Small cell lung carcinoma and Cutaneous neuroendocrine carcinoma.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Hepatocellular carcinoma to the study's metadata/MeSH terms. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded 'Gastric cancer' to the study keywords/terms, aligning the record with the study’s focus on gastric cancer (including stomach and GEJ).SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.4.2 added. The prior v3.4.1 revision and the government funding lapse notice were removed.SummaryDifference0.4%

- Check70 days agoChange DetectedIntroduced a site-wide notice about a lapse in government funding and updated operating status, including links to cc.nih.gov and opm.gov. Also updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 with Immune Therapies in Advanced Malignancies Clinical Trial page.